BACKGROUND: Acetylation of heat shock protein 90 (Hsp90) regulates downstream hormone signaling via the glucocorticoid receptor (GR), but the role of this molecular mechanism in stress homeostasis is poorly understood. We tested whether acetylation of Hsp90 in the brain predicts and modulates the behavioral sequelae of a mouse model of social stress. METHODS: Mice subjected to chronic social defeat stress were stratified into resilient and vulnerable subpopulations. Hypothalamic-pituitary-adrenal axis function was probed using a dexamethasone/corticotropin-releasing factor test. Measurements of Hsp90 acetylation, Hsp90-GR interactions, and GR translocation were performed in the dorsal raphe nucleus. To manipulate Hsp90 acetylation, we pharmacologically inhibited histone deacetylase 6, a known deacetylase of Hsp90, or overexpressed a point mutant that mimics the hyperacetylated state of Hsp90 at lysine K294. RESULTS: Lower acetylated Hsp90, higher GR-Hsp90 association, and enhanced GR translocation were observed in dorsal raphe nucleus of vulnerable mice after chronic social defeat stress. Administration of ACY-738, a histone deacetylase 6-selective inhibitor, led to Hsp90 hyperacetylation in brain and in neuronal culture. In cell-based assays, ACY-738 increased the relative association of Hsp90 with FK506 binding protein 51 versus FK506 binding protein 52 and inhibited hormone-induced GR translocation. This effect was replicated by overexpressing the acetylation-mimic point mutant of Hsp90. In vivo, ACY-738 promoted resilience to chronic social defeat stress, and serotonin-selective viral overexpression of the acetylation-mimic mutant of Hsp90 in raphe neurons reproduced the behavioral effect of ACY-738. CONCLUSIONS: Hyperacetylation of Hsp90 is a predictor and causal molecular determinant of stress resilience in mice. Brain-penetrant histone deacetylase 6 inhibitors increase Hsp90 acetylation and modulate GR chaperone dynamics offering a promising strategy to curtail deleterious socioaffective effects of stress and glucocorticoids.
BACKGROUND: Acetylation of heat shock protein 90 (Hsp90) regulates downstream hormone signaling via the glucocorticoid receptor (GR), but the role of this molecular mechanism in stress homeostasis is poorly understood. We tested whether acetylation of Hsp90 in the brain predicts and modulates the behavioral sequelae of a mouse model of social stress. METHODS:Mice subjected to chronic social defeat stress were stratified into resilient and vulnerable subpopulations. Hypothalamic-pituitary-adrenal axis function was probed using a dexamethasone/corticotropin-releasing factor test. Measurements of Hsp90 acetylation, Hsp90-GR interactions, and GR translocation were performed in the dorsal raphe nucleus. To manipulate Hsp90 acetylation, we pharmacologically inhibited histone deacetylase 6, a known deacetylase of Hsp90, or overexpressed a point mutant that mimics the hyperacetylated state of Hsp90 at lysine K294. RESULTS: Lower acetylated Hsp90, higher GR-Hsp90 association, and enhanced GR translocation were observed in dorsal raphe nucleus of vulnerable mice after chronic social defeat stress. Administration of ACY-738, a histone deacetylase 6-selective inhibitor, led to Hsp90 hyperacetylation in brain and in neuronal culture. In cell-based assays, ACY-738 increased the relative association of Hsp90 with FK506 binding protein 51 versus FK506 binding protein 52 and inhibited hormone-induced GR translocation. This effect was replicated by overexpressing the acetylation-mimic point mutant of Hsp90. In vivo, ACY-738 promoted resilience to chronic social defeat stress, and serotonin-selective viral overexpression of the acetylation-mimic mutant of Hsp90 in raphe neurons reproduced the behavioral effect of ACY-738. CONCLUSIONS: Hyperacetylation of Hsp90 is a predictor and causal molecular determinant of stress resilience in mice. Brain-penetrant histone deacetylase 6 inhibitors increase Hsp90 acetylation and modulate GR chaperone dynamics offering a promising strategy to curtail deleterious socioaffective effects of stress and glucocorticoids.
Authors: Linda Yang; Fumiko Isoda; Kelvin Yen; Steven P Kleopoulos; William Janssen; Xiaoning Fan; Jason Mastaitis; Ambrose Dunn-Meynell; Barry Levin; Rory McCrimmon; Robert Sherwin; Sergei Musatov; Charles V Mobbs Journal: Am J Physiol Endocrinol Metab Date: 2012-02-07 Impact factor: 4.310
Authors: Stephen J Haggarty; Kathryn M Koeller; Jason C Wong; Christina M Grozinger; Stuart L Schreiber Journal: Proc Natl Acad Sci U S A Date: 2003-04-03 Impact factor: 11.205
Authors: Torsten Klengel; Divya Mehta; Christoph Anacker; Monika Rex-Haffner; Jens C Pruessner; Carmine M Pariante; Thaddeus W W Pace; Kristina B Mercer; Helen S Mayberg; Bekh Bradley; Charles B Nemeroff; Florian Holsboer; Christine M Heim; Kerry J Ressler; Theo Rein; Elisabeth B Binder Journal: Nat Neurosci Date: 2012-12-02 Impact factor: 24.884
Authors: Sofie Celen; Johanna Rokka; Tonya M Gilbert; Michel Koole; Isabeau Vermeulen; Kim Serdons; Frederick A Schroeder; Florence F Wagner; Tom Bleeser; Baileigh G Hightower; Jiyun Hu; Dania Rahal; M Hassan Beyzavi; Wim Vanduffel; Koen Van Laere; Janice E Kranz; Jacob M Hooker; Guy Bormans; Christopher J Cawthorne Journal: ACS Chem Neurosci Date: 2020-03-19 Impact factor: 4.418
Authors: Shannon L Gillespie; Amanda M Mitchell; Jennifer M Kowalsky; Lisa M Christian Journal: Psychoneuroendocrinology Date: 2018-07-05 Impact factor: 4.905
Authors: Gopalkumar Rakesh; Rajendra A Morey; Anthony S Zannas; Zainab Malik; Christine E Marx; Ashley N Clausen; Michael D Kritzer; Steven T Szabo Journal: Mol Psychiatry Date: 2019-03-13 Impact factor: 15.992
Authors: Steven C Wyler; W Clay Spencer; Noah H Green; Benjamin D Rood; LaTasha Crawford; Caryne Craige; Paul Gresch; Douglas G McMahon; Sheryl G Beck; Evan Deneris Journal: J Neurosci Date: 2016-02-03 Impact factor: 6.167